Product image of Nicorette Quickmist (Nicotine) supplied by GNH India

Nicorette Quickmist

Active Ingredient:
Nicotine
Origin:
EU

Nicorette Quickmist (Nicotine)

Nicotine, the active ingredient in Nicorette Quickmist, is a nicotine replacement therapy presented as a spray for oromucosal use. It helps adults who want to quit smoking by reducing withdrawal symptoms and cravings.
GNH India supplies Nicorette Quickmist as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Manufacturer / TM Owner

Mcneil Products Limited (High Wycombe)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nicorette Quickmist, a nicotine replacement therapy, is used in smoking cessation to manage nicotine dependence.

  • Smoking cessation: assists adult smokers in reducing cravings and withdrawal symptoms during quit attempts.
  • Relapse prevention: supports individuals who have recently quit to maintain abstinence.
  • Nicotine dependence: provides controlled nicotine delivery to replace cigarettes.

How It Works

  • Nicotine in Nicorette Quickmist acts as an agonist at nicotinic acetylcholine receptors in the central nervous system, partially stimulating these receptors to mimic the pharmacologic effects of tobacco‑derived nicotine. This reduces the intensity of withdrawal symptoms and cravings, facilitating a gradual reduction in cigarette consumption while the user transitions away from smoking.

Side Effects

Nicorette Quickmist may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Throat irritation: mild soreness or scratchiness in the throat.
  • Mouth irritation: tingling or burning sensation in the oral cavity.
  • Cough: occasional dry cough after use.
  • Nausea: feeling of queasiness.
  • Headache: mild to moderate headache.
  • Dizziness: light‑headed sensation.

Serious or Rare Side Effects

  • Allergic reaction: rash, itching, swelling, or difficulty breathing.
  • Chest pain: unexpected discomfort in the chest area.
  • Rapid heartbeat: palpitations or increased heart rate.
  • Severe skin rash: widespread or blistering rash.
  • Mouth ulcers: painful sores in the mouth.
  • Hypotension: unusually low blood pressure.

Precautions & Warnings

When using Nicorette Quickmist, consider the following safety measures.

  • Assess cardiovascular status: avoid use in patients with recent myocardial infarction or uncontrolled hypertension.
  • Evaluate nicotine tolerance: do not exceed recommended usage if the user is nicotine‑naïve.
  • Monitor for psychiatric symptoms: be alert to mood changes or increased anxiety.
  • Avoid use in children and adolescents: product is intended for adult smokers only.
  • Do not combine with other nicotine products: concurrent use may increase risk of overdose.
  • Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.

Avoid Interactions

Nicorette Quickmist can interact with certain medications and substances.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): additive sympathomimetic effects may increase blood pressure.
  • Other nicotine products: concurrent use can lead to nicotine toxicity.
  • Bupropion: heightened seizure risk when combined.

Moderate Interactions (Monitor Closely)

  • Caffeine: may exacerbate jitteriness or palpitations.
  • Alcohol: can enhance nicotine’s cardiovascular effects.
  • Certain antihypertensives: nicotine may reduce their efficacy, requiring monitoring.

Frequently Asked Questions

Nicorette Quickmist is an over‑the‑counter nicotine replacement product designed to help adult smokers quit by delivering controlled amounts of nicotine through an oromucosal spray, thereby reducing cravings and withdrawal symptoms during a quit attempt.

The nicotine in Nicorette Quickmist binds to nicotinic acetylcholine receptors in the brain, partially stimulating them. This mimics the effect of cigarette‑derived nicotine, easing withdrawal symptoms while allowing the user to gradually lower nicotine exposure and break the smoking habit.

The specific dosing regimen for Nicorette Quickmist is determined by the prescribing clinician or pharmacist based on the individual’s smoking history, nicotine dependence level, and response to therapy. Users should follow the instructions provided by their healthcare professional.

Safety data for Nicorette Quickmist in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits of smoking cessation against any possible risks to the fetus or infant before recommending use in these populations.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nicorette Quickmist delivers nicotine via an oromucosal spray, offering rapid absorption and flexible dosing compared with patches or gum. This can provide quicker relief of cravings for some users, while patches provide steady plasma levels and gum offers chewable dosing. Choice depends on personal preference and clinical guidance.

Store Nicorette Quickmist at ambient temperature, below 25 °C, in its original container. Keep the product away from moisture and direct sunlight, and ensure the spray nozzle is capped when not in use to maintain product integrity.

Nicorette Quickmist is administered by spraying the prescribed number of sprays into the mouth, typically onto the buccal mucosa, and holding it there briefly before swallowing. Users should avoid eating or drinking for a short period after each dose to ensure optimal absorption.

Serious risks, though rare, include severe allergic reactions such as rash, swelling, or breathing difficulty, as well as chest pain, rapid heartbeat, and significant drops in blood pressure. Users experiencing any of these symptoms should seek immediate medical attention.

Nicorette Quickmist should not be used by individuals under 18 years of age, non‑smokers, or anyone who is allergic to nicotine or any component of the spray. It is also contraindicated in patients with recent myocardial infarction, uncontrolled hypertension, or severe cardiovascular disease without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nicotine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT